Gala­pa­gos beefs up its fi­bro­sis pipeline, las­so­ing 4 more pro­grams and tak­ing a stake in small Cana­di­an part­ner

With big mon­ey pacts with Gilead and Ab­b­Vie un­der its belt, Gala­pa­gos has be­come a hefty part­ner to small­er biotech play­ers in its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland